CMPS logo

CMPS
COMPASS Pathways

8,135
Mkt Cap
$531.35M
Volume
1.31M
52W High
$8.90
52W Low
$2.25
PE Ratio
-1.81
CMPS Fundamentals
Price
$5.53
Prev Close
$5.58
Open
$5.63
50D MA
$6.42
Beta
1.37
Avg. Volume
2.45M
EPS (Annual)
-$3.09
P/B
-10.05
Rev/Employee
$0.00
$530.23
Loading...
Loading...
News
all
press releases
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of "Moderate Buy" from Brokerages
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine analysts that are currently covering the company, Marketbeat Ratings...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the...
Business Wire·4d ago
News Placeholder
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees...
Business Wire·4d ago
News Placeholder
Compass Pathways PLC Sponsored ADR $CMPS Shares Bought by Hennion & Walsh Asset Management Inc.
Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS - Free Report) by 169.0% during the fourth quarter, according to the company in...
MarketBeat·11d ago
News Placeholder
Compass Pathways (NASDAQ:CMPS) Given New $18.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group cut their price target on shares of Compass Pathways from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday...
MarketBeat·16d ago
News Placeholder
What is HC Wainwright's Estimate for CMPS Q1 Earnings?
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS - Free Report) - Stock analysts at HC Wainwright issued their Q1 2027 EPS estimates for shares of Compass Pathways in a research note issued on Wednesday, March 25th. HC Wainwright analyst P. Trucchio expects that the company will earn ($0.42) per shar...
MarketBeat·17d ago
News Placeholder
Compass Pathways (NASDAQ:CMPS) Trading 9.7% Higher - What's Next?
Compass Pathways (NASDAQ:CMPS) Trading Up 9.7% - Should You Buy...
MarketBeat·17d ago
News Placeholder
Morgan Stanley Has Lowered Expectations for Compass Pathways (NASDAQ:CMPS) Stock Price
Morgan Stanley reduced their target price on shares of Compass Pathways from $18.00 to $16.00 and set an "overweight" rating for the company in a report on Wednesday...
MarketBeat·17d ago
News Placeholder
Compass Pathways (NASDAQ:CMPS) Issues Quarterly Earnings Results
Compass Pathways (NASDAQ:CMPS - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($1.00) earnings per share (EPS) for the quarter, missing the consensus...
MarketBeat·18d ago
News Placeholder
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported the fourth quarter and full-year...
Business Wire·18d ago
<
1
2
...
>

Latest CMPS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.